Back to search

Article

A BODIPY-naphtholimine-BF <sub>2</sub> dyad for precision photodynamic therapy, targeting and dual imaging of endoplasmic reticulum and lipid droplets in cancer

2024-01-08

Abstract excerpt

<h4>ABSTRACT</h4> Currently effective therapeutic modalities for pancreatic ductal adenocarcinoma (PDAC) is not available, leading to gloomy prognosis and ~6-months median patient survival. Recent advances showed the promise of photodynamic therapy (PDT) for PDAC patients. Next generation photosensitizers (PS) are based on “organelle-targeted-PDT” and provides new paradigm in the field of precision medicines to a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7d54968-716e-55e9-a322-30abfb8e42da
DOI
10.1101/2024.01.07.574513
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A BODIPY-naphtholimine-BF <sub>2</sub> dyad for precision photodynamic therapy, targeting and dual imaging of endoplasmic reticulum and lipid droplets in cancerDOI 10.1101/2024.01.07.574513
Select a neighboring publication to make it the new centre.